Drug Overview
Quercetin is a powerful, naturally occurring compound found in many “superfoods” like onions, apples, and berries. In the medical world, it is known as a Targeted Therapy and a Smart Drug because of its ability to influence specific biological pathways in the body. While it is widely used as a nutritional supplement, it is a significant subject of research in oncology for its ability to act as a “chemosensitizer”—meaning it can help make cancer cells more vulnerable to traditional treatments.
Quercetin belongs to a group of plant pigments called flavonoids. It acts as a potent antioxidant and anti-inflammatory agent. For patients, it is often viewed as a bridge between natural wellness and clinical medicine, offering a way to support the body’s defenses while potentially interfering with the survival mechanisms that cancer cells use to grow and hide.
- Generic Name: Quercetin
- US Brand Names: Quercetin, Quercenase, various dietary supplement brands (e.g., Thorne, Now Foods).
- Drug Class: Flavonoid; Antioxidant; Senolytic Agent.
- Route of Administration: Oral (Capsules/Powder); Intravenous (IV) in clinical trial settings.
- FDA Approval Status: Recognized as GRAS (Generally Recognized as Safe) for use in food; Investigational (Not FDA-approved) for the treatment of cancer or specific diseases.
What Is It and How Does It Work? (Mechanism of Action)

To understand how quercetin works, imagine a cancer cell as a busy factory. Quercetin acts like a specialized inspector that enters the factory and shuts down the machines that are causing smoke (inflammation) or making the factory grow too fast (tumor growth).
At the molecular level, quercetin works through several complex signaling pathways:
- Inducing Apoptosis: Quercetin can trigger “programmed cell death” (apoptosis) in cancer cells. It does this by activating proteins called caspases and inhibiting “survival” proteins like Bcl-2. Essentially, it forces the cancer cell to realize it is broken and destroy itself.
- Cell Cycle Arrest: It stops cancer cells from dividing by blocking specific checkpoints in the cell cycle (specifically the G1/S or G2/M phases). It targets the PI3K/Akt/mTOR pathway, which is the “master switch” many cancers use to grow uncontrollably.
- Senolytic Activity: Quercetin is a “senolytic.” This means it helps clear out “zombie cells”—old cells that refuse to die and instead pump out chemicals that cause inflammation and aging in healthy tissue.
- Anti-Angiogenesis: It can block the signals that tumors send to grow new blood vessels. By interfering with VEGF (Vascular Endothelial Growth Factor), quercetin effectively “starves” the tumor of the nutrients it needs to expand.
FDA-Approved Clinical Indications
As of early 2026, quercetin is primarily regulated as a dietary supplement. It does not have FDA-approved “labels” for treating specific diseases, but it is used by healthcare professionals for several investigational and supportive roles.
Oncological Uses (Investigational)
- Chemosensitization: Used in trials to help standard chemotherapy (like paclitaxel or cisplatin) work more effectively.
- Cancer Prevention: Studied for its potential to reduce the risk of colon and prostate cancers in high-risk groups.
- Reducing Toxicity: Used to help protect healthy organs from the side effects of radiation and chemotherapy.
Non-Oncological Uses
- Allergy Management: Actively used to stabilize mast cells and reduce histamine release.
- Cardiovascular Support: Helping to maintain healthy blood pressure and reduce “bad” LDL cholesterol.
- Anti-Viral Support: Investigated for its ability to block viral entry into cells during respiratory outbreaks.
Dosage and Administration Protocols
Because quercetin is often used as a supplement, doses can vary. However, in clinical studies, specific ranges are followed.
| Use Case | Standard Dosage | Frequency | Administration Notes |
| General Health | 500 mg | Once or twice daily | Best taken with a meal containing fats. |
| Clinical Trials (Oral) | 1,000 mg – 2,000 mg | Divided into 2 doses | Often combined with Vitamin C or Bromelain. |
| Clinical Trials (IV) | Calculated by weight | Weekly Infusion | Administered by a physician in a clinic. |
| Senolytic Protocol | 500 mg – 1,000 mg | Intermittent (e.g., 2 days on) | Often paired with Dasatinib in aging studies. |
Dose Adjustments:
- Renal (Kidney) Insufficiency: Caution is advised. Very high doses of quercetin (especially via IV) have been linked to kidney stress in rare cases.
- Hepatic (Liver) Insufficiency: Standard oral doses are generally safe, but monitoring liver enzymes is recommended during long-term use.
Clinical Efficacy and Research Results
Recent clinical data from 2020–2025 highlights quercetin’s growing role in “integrative” oncology.
- Prostate Cancer: Numerical data from Phase II trials suggest that quercetin can help lower PSA levels (a marker for prostate cancer) in men with chronic inflammation of the prostate.
- Survival Rates in Combination Therapy: In laboratory and early clinical models, quercetin increased the “kill rate” of chemotherapy against resistant breast cancer cells by approximately 25% to 30%.
- Senolytic Success: In trials focusing on aging (2024), the combination of quercetin and dasatinib was shown to significantly reduce the number of senescent (zombie) cells in human tissue, leading to improved physical function in older adults.
Safety Profile and Side Effects
Black Box Warning:
None. Quercetin is considered very safe for most people when taken at recommended doses.
Common Side Effects (>10%)
- Headache: Usually mild and occurs when first starting the supplement.
- Nausea: Stomached upset if taken without food.
- Tingling Sensation: A brief “pins and needles” feeling in the arms or legs (rarely reported at high doses).
Serious Adverse Events
- Kidney Damage (Nephrotoxicity): Reported only at extremely high doses (usually >1 gram per day given intravenously).
- Drug Interactions: Quercetin can change how the liver processes other medicines, making them either too strong or too weak.
Management Strategies
- The “Washout” Period: If side effects occur, stopping the supplement for 48 hours usually resolves all symptoms.
- Absorption Support: Since quercetin is hard for the body to absorb, look for “phytosome” or “liposomal” versions to get the same benefit with a lower dose.
Research Areas
Quercetin is a star in the field of Regenerative Medicine. It is currently being studied for its role as a “senomorphic” and “senolytic” agent. Researchers are investigating how quercetin can help Stem Cells stay “young” and functional by protecting them from oxidative stress. In Immunotherapy, studies are looking at whether quercetin can help “re-program” the immune system to recognize hidden cancer cells, potentially making it a valuable addition to modern “Checkpoint Inhibitor” treatments.
Patient Management and Practical Recommendations
Pre-treatment Tests to be Performed
- Baseline Kidney Function (GFR/Creatinine): To ensure the body can filter the compound.
- Liver Enzyme Panel (ALT/AST).
Precautions During Treatment
- Blood Thinners: Quercetin has mild anti-clotting properties. If you are on warfarin or aspirin, talk to your doctor before starting.
- Thyroid Interaction: High doses may interfere with thyroid hormone absorption.
“Do’s and Don’ts” List
- Do take quercetin with a meal that contains healthy fats (like olive oil or avocado) to help your body absorb it.
- Do combine with Vitamin C, as it helps “recycle” quercetin in your blood, making it last longer.
- Don’t take quercetin within 2 days of surgery due to its effect on blood thickness.
- Don’t assume that “more is better.” Stick to the dose recommended by your healthcare provider to protect your kidneys.
Legal Disclaimer
Standard medical information disclaimer: This guide is for informational purposes only and does not constitute medical advice.Quercetin is a dietary supplement and is not intended to diagnose, treat, cure, or prevent any disease. Always consult with a licensed oncologist or physician before adding any supplement to your cancer treatment plan. This content reflects research and clinical data available as of early 2026.



